151 related articles for article (PubMed ID: 26002576)
1. Elevated RABEX-5 protein expression predicts poor prognosis in combined small cell lung cancer.
Zhang F; Zhang M; Hu G; Cai Q; Xu T
Tumour Biol; 2015 Nov; 36(11):8287-93. PubMed ID: 26002576
[TBL] [Abstract][Full Text] [Related]
2. Elevated RABEX-5 expression predicts poor prognosis in non-small-cell lung cancer.
Zhang F; Jia Y; Kong F; Hu G; Cai Q; Xu T
Am J Cancer Res; 2015; 5(9):2849-55. PubMed ID: 26609490
[TBL] [Abstract][Full Text] [Related]
3. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
4. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.
Qiao M; Hu G
Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706
[TBL] [Abstract][Full Text] [Related]
5. Higher RABEX-5 mRNA predicts unfavourable survival in patients with colorectal cancer.
Zhang JS; Yang LQ; Du BR; Gao H
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2372-2376. PubMed ID: 28617553
[TBL] [Abstract][Full Text] [Related]
6. Expression of RABEX-5 and its clinical significance in prostate cancer.
Zhang H; Cheng S; Wang A; Ma H; Yao B; Qi C; Liu R; Qi S; Xu Y
J Exp Clin Cancer Res; 2014 Apr; 33(1):31. PubMed ID: 24716822
[TBL] [Abstract][Full Text] [Related]
7. High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer.
Shao N; Cai Q
Tumour Biol; 2015 Nov; 36(11):8465-70. PubMed ID: 26026588
[TBL] [Abstract][Full Text] [Related]
8. Metformin use improves the survival of diabetic combined small-cell lung cancer patients.
Kong F; Gao F; Liu H; Chen L; Zheng R; Yu J; Li X; Liu G; Jia Y
Tumour Biol; 2015 Sep; 36(10):8101-6. PubMed ID: 25983003
[TBL] [Abstract][Full Text] [Related]
9. Mitotic arrest deficient-like 1 is correlated with poor prognosis in small-cell lung cancer after surgical resection.
Li D; Meng Q; Zhang H; Feng T; Liu M; Cai L
Tumour Biol; 2016 Apr; 37(4):4393-8. PubMed ID: 26499943
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
12. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
13. The downregulation of Bcl-xL/Bcl-2-associated death promoter indicates worse outcomes in patients with small cell lung carcinoma.
Yu Y; Zhong Z; Guan Y
Int J Clin Exp Pathol; 2015; 8(10):13075-82. PubMed ID: 26722503
[TBL] [Abstract][Full Text] [Related]
14. Favorable Disease-free Survival Associated with Programmed Death Ligand 1 Expression in Patients with Surgically Resected Small-cell Lung Cancer.
Toyokawa G; Takada K; Haratake N; Takamori S; Akamine T; Katsura M; Fujishita T; Shoji F; Okamoto T; Oda Y; Maehara Y
Anticancer Res; 2016 Aug; 36(8):4329-36. PubMed ID: 27466552
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
16. [Expression of LncRNA AK09398 and Relationship with Prognosis in Patients with Small Cell Lung Cancer].
Liu B; Liu X; Yang Y; Ge J; Li J
Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):754-759. PubMed ID: 27866518
[TBL] [Abstract][Full Text] [Related]
17. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J
Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
Wang X; Jiang R; Li K
Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancer.
Mancuso G; Bovio E; Rena O; Rrapaj E; Mercalli F; Veggiani C; Paganotti A; Andorno S; Boldorini R
Cancer Cytopathol; 2016 Sep; 124(9):621-9. PubMed ID: 27153322
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer.
Chen S; Wu H; Lv N; Wang H; Wang Y; Tang Q; Shao H; Sun C
Biomed Pharmacother; 2016 Aug; 82():583-8. PubMed ID: 27470400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
